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INTRODUCTION: 
In the present study and research novel drug delivery 
systems are developed for expanding markets/indications, 
extending product life cycles and generating opportunities. 
Oral administration is the most popular route for systemic 
effects due to its ease of ingestion, pain, avoidance, 
versatility and most importantly patient compliance. In 
these solid formulations do not require sterile conditions 
and are therefore, less expensive to manufacture. Patient 
compliance, high-precision dosing, and manufacturing 
efficiency make tablets the solid dosage form of choice. 
Excipients and equipments choices will be significantly 
affected should solid dosage form technologies change in 
response to the unprecedented shifts in the drug discovery 
such as genomics. The development of enhanced oral 
protein delivery technology by immediate release tablets 
which may release the drugs at an enhanced rate are very 
promising for the delivery of poorly soluble drugs high 
molecular weight protein and peptide . The oral route 
remains the perfect route for the administration of 
therapeutic agents because the low cost of therapy, 
manufacturing and ease of administration lead to high 
levels of patient compliance. Many patients require quick 
onset of action in particular therapeutic condition and 
consequently immediate release of medicament is required. 
It is estimated that50% of the population is affected by this 
problem, which results in a high incidence of ineffective 
therapy. 
Definition: 
Immediate release tablets are those which disintegrate 
rapidly and get dissolved to release the medicaments. 
Immediate release may be provided for by way of an 
appropriate pharmaceutically acceptable diluent or carrier, 
which diluent or carrier does not prolong, to an appreciable 
extent, the rate of drug release and/or absorption. This term 
excludes formulations which are adapted to provide for 
“modified”, “controlled”, “sustained”, “prolonged”, 
“extended” or “delayed” release of drug. 
Release term includes the provision (or presentation) of 
drug from the formulation to the gastrointestinal tract, to 
body tissues and/or into systemic circulation. For 
gastrointestinal tract release, the release is under pH 
conditions such as pH=1 to 3, especially at, or about, 
pH=1. In one aspect of the invention a formulation as 
described herein with a compound of formula (I), or an 
acid addition salt thereof, in crystalline form releases drug 
under a range of pH conditions. In another aspect of the 
invention a formulation as described herein with a 
compound of formula (I), or an acid addition salt thereof, 
releases drug under pH conditions such as pH=1 to 3, 
especially at, or about, pH=1. Thus, formulations of the 
invention may release at least 70% (preferably 80%) of 
active ingredient within 4 hours, such as within 3 hours, 
preferably 2 hours, more preferably within 1.5 hours, and 
especially within an hour (such as within 30 minutes), of 
administration, whether this be oral or parenteral. 
Pharmacokinetics: 
It is the study of absorption, distribution, metabolism and 
excretion. After absorption, drug attains therapeutic level 
and therefore elicits pharmacological effect, so both rate 
and extend of absorption is important. In conventional 
dosage form there is delay in disintegration and therefore 
dissolution is fast. Drug distribution depends on many 
factors like tissue permeability, perfusion rate, binding of 
drug to tissue, disease state, drug interaction etc. 
Duration and intensity of action depends upon rate of drug 
removal from the body or site of action i.e. 
biotransformation. Decrease in liver volume, regional 
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blood flow to liver reduces the biotransformation of drug 
through oxidation, reduction and hydrolysis. Excretion by 
renal clearance is slowed, thus half-life of renal excreted 
drugs increase. 
Pharmacodynamic: 
 Drug reception interaction impaired in elderly as well 
as in young adult due to undue development of 
organ. 
 Decreased ability of the body to respond reflexive 
stimuli, cardiac output, and orthostatic hypotension 
may see in taking antihypertensive like prazosin. 
 Decreased sensitivity of the CVS to α-adrenergic 
agonist and antagonist. 
 Immunity is less and taken into consideration while 
administered antibiotics. 
 Altered response to drug therapy-elderly show 
diminished bronchodilator effect of theophylline 
shows increased sensitivity to barbiturates. 
 Concomitant illnesses are often present in elderly, 
which is also taken into consideration, while multiple 
drug therapy prescribed. 
Research workers have clinically evaluated drug 
combination for various classes’ cardiovascular 
agents, diuretics, anti-hypertensive etc. for immediate 
release dosage forms. The combination choice 
depends on disease state of the patient. 
Problems with Existing Oral Dosage Form: 
 Patient may suffer from tremors therefore they have 
difficulty to take powder and liquids. In dysphasia 
physical obstacles and adherence to an oesophagus 
may cause gastrointestinal ulceration. 
 Swallowing of solid dosage forms like tablet and 
capsules and produce difficulty for young adult of 
incomplete development of muscular and nervous 
system and elderly patients suffer from dysphasia. 
 Liquid medicaments (suspension and emulsion) are 
packed in multidose container; therefore achievement 
of uniformity in the content of each dose may be 
difficult. 
 Buccal and sublingual formation may cause irritation 
to oral mucosa, so patients refused to use such 
medications. 
 Cost of products is main factor as parenteral 
formulations are most costly and discomfort. 
 
Desired Criteria for Immediate Release Drug Delivery 
System: 
Immediate release dosage form should- 
 In the case of solid dosage it should dissolve or 
disintegrate in the stomach within a short period. 
 In the case of liquid dosage form it should be 
compatible with taste masking. 
 Be portable without fragility concern. 
 Have a pleasing mouth feel. 
 It should not leave minimal or no residue in the 
mouth after oral administration. 
 Exhibit low sensitivity to environmental condition as 
humidity and temperature. 
 Be manufactured using conventional processing and 
packaging equipment at low cost. 
 Rapid dissolution and absorption of drug, which may 
produce rapid onset of action. 
Merits of Immediate Release Drug Delivery System: 
 Improved compliance/added convenience 
 Improved stability, bioavailability 
 Suitable for controlled/sustained release actives 
 Allows high drug loading. 
 Ability to provide advantages of liquid medication in 
the form of solid preparation. 
 Adaptable and amenable to existing processing and 
packaging machinery 
 Cost- effective 
 Improved solubility of the pharmaceutical 
composition; 
 Decreased disintegration and dissolution times for 
immediate release oral dosage forms; 
Other Excipients: 
Excipients balance the properties of the actives in 
immediate release dosage forms. This demands a thorough 
understanding of the chemistry of these excipients to 
prevent interaction with the actives. Determining the cost 
of these ingredients is another issue that needs to be 
addressed by formulators. The role of excipients is 
important in the formulation of fast-melting tablets. These 
inactive food-grade ingredients, when incorporated in the 
formulation, impart the desired organoleptic properties and 
product efficacy. Excipients are general and can be used 
for a broad range of actives, except some actives that 
require masking agents. 
Bulking Materials: 
Bulking materials are significant in the formulation of fast-
melting tablets. The material contributes functions of a 
diluent, filler and cost reducer. Bulking agents improve the 
textural characteristics that in turn enhance the 
disintegration in the mouth, besides; adding bulk also 
reduces the concentration of the active in the composition. 
The recommended bulking agents for this delivery system 
should be more sugar-based such as mannitol, 
polydextrose, lactitol, DCL (direct compressible lactose) 
and starch hydrolystate for higher aqueous solubility and 
good sensory perception. Mannitol in particular has high 
aqueous solubility and good sensory perception. Bulking 
agents are added in the range of 10 percent to about 90 
percent by weight of the final composition . 
Emulsifying Agents: 
Emulsifying agents are important excipients for 
formulating immediate release tablets they aid in rapid 
disintegration and drug release. In addition, incorporating 
emulsifying agents is useful in stabilizing the immiscible 
blends and enhancing bioavailability. A wide range of 
emulsifiers is recommended for fast-tablet formulation, 
including alkyl sulfates, propylene glycol esters, lecithin, 
sucrose esters and others. These agents can be incorporated 
in the range of 0.05 percent to about 15 percent by weight 
of the final composition. 
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Lubricants: 
Lubricants, though not essential excipients, can further 
assist in making these tablets more palatable after they 
disintegrate in the mouth. Lubricants remove grittiness and 
assist in the drug transport mechanism from the mouth 
down into the stomach. 
Flavours and Sweeteners: 
Flavours and taste-masking agents make the products more 
palatable and pleasing for patients. The addition of these 
ingredients assists in overcoming bitterness and 
undesirable tastes of some active ingredients. Both natural 
and synthetic flavours can be used to improve the 
organoleptic characteristic of fast-melting tablets. 
Formulators can choose from a wide range of sweeteners 
including sugar, dextrose and fructose, as well as non-
nutritive sweeteners such as aspartame, sodium saccharin, 
sugar alcohols and sucralose. The addition of sweeteners 
contributes a pleasant taste as well as bulk to the 
composition. 
Super Disintegrants: 
A disintegrant is an excipient, which is added to a tablet or 
capsule blend to aid in the break up of the compacted mass 
when it is put into a fluid environment. 
Advantages: 
 Effective in lower concentrations 
 Less effect on compressibility and flowability 
 More effective intragranularly 
Some super disintegrants are: 
1. Sodium Starch Glycolate (Explotab, primogel) 
used in concentration of 2-8 % & optimum is 4%. 
Mechanism of Action: Rapid and extensive swelling 
with minimal gelling. Microcrystalline cellulose 
(Synonym: Avicel, celex) used in concentration of 2-
15% of tablet weight. And Water wicking 
2. Cross-linked Povidone or crospovidone 
(Kollidone) used in concentration of 2-5% of weight 
of tablet. Completely insoluble in water. 
Mechanism of Action: Water wicking, swelling and 
possibly some deformation recovery. Rapidly 
disperses and swells in water, but does not gel even 
after prolonged exposure. Greatest rate of swelling 
compared to other disintegrants. Greater surface area 
to volume ratio than other disintegrants. 
3. Low-substituted hydroxyl propyl cellulose, which 
is insoluble in water. Rapidly swells in water. Grades 
LH-11 and LH-21 exhibit the greatest degree of 
swelling. Certain grades can also provide some 
binding properties while retaining disintegration 
capacity. Recommended concentration 1-5% 
4. Cross linked carboxy methyl cellulose sodium 
(Ac-Di-sol) Croscarmellose sodium: 
Mechanism of Action: Wicking due to fibrous 
structure, swelling with minimal gelling. Effective         
Concentrations: 1-3% Direct Compression, 2-4% 
Wet Granulation 
Conventional Technique Used in the Preparation of 
Immediate Release Tablets: 
 Tablet molding technique 
 Direct compression technique 
 Wet granulation technique 
 Mass extrusion technique 
 By solid dispersions 
Tablet Molding: 
In this technology, water-soluble ingredients are used so 
that tablet disintegrate and dissolve rapidly. The powder 
blend is moistened with a hydro alcoholic solvent and is 
molded in to tablet using compression pressure lower than 
used in conventional tablets compression. The solvent is 
then removed by air-drying. Molded tablets have a porous 
structure that enhances dissolution. Two problems 
commonly encountered are mechanical strength and poor 
taste masking characteristics. Using binding agents such as 
sucrose, acacia or poly vinyl pyrrolidone can increase the 
mechanical strength of the tablet. To overcome poor taste 
masking characteristic Van Scoik incorporated drug 
containing discrete particles, which were formed by spray 
congealing a molten mixture of hydrogenated cottonseed 
oil, sodium bicarbonate, lecithin, polyethylene glycol and 
active ingredient into a lactose based tablet triturate form. 
Direct Compression Method: 
In this method, tablets are compressed directly from the 
mixture of the drug and excipients without any preliminary 
treatment. The mixture to be compressed must have 
adequate flow properties and cohere under pressure thus 
making pretreatment as wet granulation unnecessary. Few 
drugs can be directly compressed into tablets of acceptable 
quality. A type of disintegrant and its proportion are of 
prime importance. The other factors to be considered are 
particle size distribution, contact angle, pore size 
distribution, tablet hardness and water absorption capacity. 
All these factors determine the disintegration. The 
disintegrant addition technology is cost effective and easy 
to implement at industrial level. 
Wet Granulation Method: 
Wet granulation is a process of using a liquid binder to 
lightly agglomerate the powder mixture. The amount of 
liquid has to be properly controlled, as over-wetting will 
cause the granules to be too hard and under-wetting will 
cause them to be too soft and friable. Aqueous solutions 
have the advantage of being safer to deal with than 
solvent-based systems but may not be suitable for drugs 
which are degraded by hydrolysis. 
Procedure 
 The active ingredient and excipients are weighed and 
mixed. 
 The wet granulate is prepared by adding the liquid 
binder–adhesive to the powder blend and mixing 
thoroughly. Examples of binders/adhesives include 
aqueous preparations of cornstarch, natural gums such 
as acacia, and cellulose derivatives such as methyl 
cellulose, gelatin, and povidone. 
 Screening the damp mass through a mesh to form 
pellets or granules. 
 Drying the granulation. A conventional tray-dryer or 
fluid-bed dryer are most commonly used. 
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 After the granules are dried, they are passed through a 
screen of smaller size than the one used for the wet 
mass to create granules of uniform size. 
Low shear wet granulation processes use very simple 
mixing equipment, and can take a considerable time to 
achieve a uniformly mixed state. High shear wet 
granulation processes use equipment that mixes the 
powder and liquid at a very fast rate, and thus speeds up 
the manufacturing process. Fluid bed granulation is a 
multiple-step wet granulation process performed in the 
same vessel to pre-heat, granulate, and dry the powders. It 
is used because it allows close control of the granulation 
process. 
Mass-Extrusion (Mass-Extrusion): 
This technology involves softening the active blend using 
the solvent mixture of water-soluble polyethylene glycol 
and methanol and subsequent expulsion of softened mass 
through the extruder or syringe to get a cylinder of the 
product into even segments using heated blade to form 
tablets. The dried cylinder can also be used to coat 
granules for bitter drugs and thereby achieve taste 
masking. 
By solid dispersions: 
When formulating such solid amorphous dispersions into 
immediate release solid dosage forms for oral 
administration to a use environment such as the GI tract of 
an animal such as a human, it is often desirable to 
maximize the amount of dispersion present in the dosage 
form. This minimizes the size of the solid dosage form 
required to achieve the desired dose. Depending on the 
drug dose, it is often desired that the solid amorphous 
dispersion comprise at least 30 wt %, preferably at least wt 
%, and more preferably at least 50 wt % or more of the 
solid dosage form. Such high drug loadings of dispersion 
in a solid dosage form minimize the dosage form's size, 
making it easier for the patient to swallow it and tending to 
improve patient compliance. 
The immediate release dosage forms containing a solid 
dispersion that enhances the solubility of a “low-solubility 
drug,” meaning that the drug may be either “substantially 
water-insoluble,” which means that the drug has a 
minimum aqueous solubility at physiologically relevant 
pH (e.g., pH 1-8) of less than 0.01 mg/mL, “sparingly 
water-soluble,” that is, has an aqueous solubility up to 
about 1 to 2 mg/mL, or even low to moderate aqueous-
solubility, having an aqueous-solubility from about 1 
mg/mL to as high as about 20 to 40 mg/mL. 
The drug dispersions used in fabricating the high loading 
immediate release dosage forms of the present invention 
comprise solid dispersions of a drug and at least one 
concentration-enhancing polymer. The concentration-
enhancing polymer is present in the dispersions used in the 
present invention in a sufficient amount so as to improve 
the concentration of the drug in a use environment relative 
to a control composition. At a minimum, the dispersions 
used in the present invention provide concentration 
enhancement relative to a control consisting of crystalline 
drug alone. Thus, the concentration-enhancing polymer is 
present in a sufficient amount so that when the dispersion 
is administered to a use environment, the dispersion 
provides improved drug concentration relative to a control 
consisting of an equivalent amount of crystalline drug, but 
with no concentration-enhancing polymer present. 
Evaluation of powder blend: 
The prepared blend is evaluated by following tests. 
1. Angle of repose 
2. Bulk density 
3. Tapped density 
4. Hauser’s ratio 
5. Carr’s index 
1. Angle of repose: 
Angle of repose was determined by using fixed funnel 
method. The fixed funnel method employ a funnel that was 
secured with its tip at a given height (2cm), above the 
graph paper that was placed on a flat horizontal surface. 
Granules or tablet blend were carefully poured through the 
funnel until the apex of the conical pile just touches the tip 
of the funnel. Thus, with r being the radius of the base of 
the conical pile. Angle of repose was calculated using the 
following equation. 
θ = tan-1 (  ) 
Here h = Height of pile 
         r = Radius of pile 
         θ = Angle of repose 
2. Bulk density: 
Bulk density was determined by pouring a weighed 
quantity of tablet blend into graduated cylinder and 
measuring the height. Bulk density is the ratio of mass of 
tablet blend to bulk volume. 
 
Here; m = weight of powder or granules (gm.) 
v = Bulk Volume (cm.3) 
π = 22/7 = 3.14 
r = Radius of Cylinder (cm.) 
h = Height reached by powder in cylinder (cm.) 
 
3. Tapped Density: 
Tapped density is ratio of mass of tablet blend to tapped 
volume of tablet blend. Accurately weighed amount of 
tablet blend poured in graduated cylinder and height is 
measured. Then cylinder was allowed to 100tap under its 
own weight onto a hard surface. The tapping was 
continued until no further change in height was noted. 
 
   Here; m = weight of powder or granules (gm.) 
v = Tapped Volume (cm.3) 
π = 22/7 = 3.14 
r = Radius of Cylinder (cm.) 
      h = Height reached by powder in cylinder after tapping 
(cm.) 
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4. Hausner’s Ratio: 
Hausner’s ratio indicates the flow properties of powder 
and measured by the ratio of tapped density to bulk 
density. Hausner’s ratio was determined by the given 
formula                                                           
 
5. Carr’s Index (Compressibility Index): 
Compressibility is the ability of powder to decrease in 
volume under pressure using bulk density and tapped 
density the percentage compressibility of powder were 
determined, which is given as carr’s compressibility index. 
It is indirectly related to the relative flow rate. Carr’s 
compressibility index was determined by the given 
formula                                                          
 
EVALUATION OF TABLETS 
These tests are as following:- 
1. Appearance 
2. Thickness 
3. Hardness 
4. Weight variation 
5. Friability 
6. Disintegration 
7. Uniformity of dispersion 
8. Wetting Time 
9. Water absorption ratio 
10. Drug content 
11. In vitro Dissolution 
12. Stability studies 
1. Appearance: 
The general appearance of tablet is its visual identity 
and all over elegance, shape, color, surface textures. 
These all parameters are essential for consumer 
acceptance. 
2. Thickness: 
The thickness of the tablets was determined by using 
vernier calipers. Randomly 10 tablets selected were 
used for determination of thickness that expressed in 
Mean± SD and unit is mm. 
3. Hardness: 
The hardness of tablet is an indication of its strength 
against resistance of tablets to capping, abrasion or 
breakage under conditions of storage, transportation 
and handling before usage. Measuring the force 
required to break the tablet across tests it. Hardness of 
10 tablets (randomly) from whole tablet batch was 
determined by Monsanto hardness tester. Hardness 
measured in kg/cm2. 
4. Weight variation: 
The weight variation test is carried out in order to 
ensure uniformity in the weight of tablets in a batch. 
The total weight of 20 tablets randomly from whole 
batch was determined and the average was calculated. 
The individual weights of the tablets were also 
determined accurately and the weight variation was 
calculated. 
5. Friability test: 
Friability is the loss of weight of tablet in the container due 
to removal of fine particles from the surface during 
transportation or handling. Roche friabilator was employed 
for finding the friability of the tablets. For tablets with an 
average weight of 0.65 g or less take a sample of whole 
tablets corresponding to about 6.5 g and for tablets with an 
average weight of more than 0.65 g take a sample of 10 
whole tablets. Roche friabilator is rotated at 25rpm for 4 
minutes for 100rounds. The tablets were dedusted and 
weighed again. The percentage of weight loss was 
calculated using the formula 
%f  x 100 
Here, 
%f = Percentage friability 
W0 = Initial weight (Before test) 
W1 = Final weight (After test) 
6. Disintegration test: 
The USP device to rest disintegration was six glass 
tubes that are “3 long, open at the top, and held against 
10” screen at the bottom end of the basket rack 
assembly. One tablet is placed in each tube and the 
basket rack is poisoned in 1 liter beaker of distilled 
water at 37± 20C, such that the tablets remain below the 
surface of the liquid on their upward movement and 
descend not closer than 2.5cm from the bottom of the 
beaker. 
7. Uniformity of dispersion: 
Two tablets were kept in 100ml water and gently 
stirred for 2 minutes. The dispersion was passed 
through 22 meshes. The tablets were considered to pass 
the test if no residue remained on the screen. 
8. Wetting Time: 
The wetting time of the tablets was measured using a 
simple procedure. Five circular tissue papers of 10cm 
diameter were placed in a petridish containing 0.2% 
w/v solution of amaranth (10ml). One tablet was 
carefully placed on the surface of the tissue paper. The 
time required for develop blue color due to amaranth 
water soluble dye on the upper surface of the tablets 
was noted as the wetting time. 
9. Water Absorption Ratio: 
A small piece of tissue paper folded twice was placed 
in a small petridish containing 6ml of water. A tablet 
was put on the paper. The wetted tablet was then 
weighed. Water absorption ratio, R was determined by 
using following formula 
R  x 100 
Here,    R = Water absorption ratio  
Wb = Weight of tablet before water absorption 
Wa = Weight of tablet after water absorption 
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10. Drug content: 
10 tablets were powdered and 100mg drug equivalent 
powder dissolved in suitable media buffer or 0.1N 
HCl. Volume of the solution made up to 100ml by that 
media. Solution was filtered and diluted 100times and 
analyzed spectrophotometrically and further 
calculation carried out to determine drug content in 
one tablet. 
11. In vitro drug release studies: 
The immediate release tablets are subjected to in vitro 
drug release studies in pH 6.8 phosphate buffer or 
0.1N HCl for 30 minutes to access the ability of the 
formulation for providing immediate drug delivery. 
Drug release studies were carried out in dissolution test 
apparatus using specified volume 900ml of dissolution 
media maintained at 37±0.20C. The tablets are kept in the 
cylindrical basket or directly placed in medium with 
paddle then rotated at 100 rpm. 5ml of the sample from the 
dissolution medium are withdrawn at each time interval (5, 
10, 15 & 30 minutes) and 5ml of fresh medium was 
replaced each time. The samples were filtered and from the 
filtrate 1ml was taken and diluted to 10ml. These samples 
were analyzed spectrophotometrically and further 
calculation was carried out to get drug release. The drug 
released data were plotted and tested with zero order 
(Cumulative % drug released Vs time), First order (Log % 
Remained Vs time). The in vitro dissolution kinetic 
parameters, dissolution rate constants, correlation 
coefficient and dissolution efficiency were calculated. 
12. Stability study: 
Stability is defined as the ability of a particular drug or 
dosage form in a specific container to remain within its 
physical, chemical, therapeutic, and toxicological 
specifications. Drug decomposition or degradation occurs 
during storage, because of chemical alteration of the active 
ingredients or due to product instability, lowering the 
concentration of the drug in the dosage form.   
Stability study of the dosage form must include a section 
for product characterization and another section to study 
the product stability during storage. Formulations are 
evaluated for their appearance, possible weight gain in 
drug content thickness, flatness, folding endurance, tensile 
strength, moisture content and moisture uptake, and in-
vitro release study by keeping dosage form in different 
temperature and humidity condition after a specified time. 
The stability study indicates that the formulation is quite 
stable at different conditions of storage. 
CONCLUSION: 
This is new enhanced oral product arising within this 
market segment and applicable to a wide range of 
therapeutic agents. Approximately one-third of the patients 
need quick therapeutic action of drug, resulting in poor 
compliance with conventional drug therapy which leads to 
reduced overall therapy effectiveness. A new dosage 
format, the immediate release pharmaceutical form has 
been developed which offers the combined advantages of 
ease of dosing and convenience of dosing. These tablets 
are designed to release the medicaments with an enhanced 
rate. Due to the constraints of the current technologies as 
highlighted above, there is an unmet need for improved 
manufacturing processes for immediate release 
pharmaceutical form that are mechanically strong, 
allowing ease of handling and packaging and with 
production costs similar to that of conventional tablets. To 
fulfill these medical needs, formulators have devoted 
considerable effort to developing a novel type of tablet 
dosage form for oral administration, one that disintegrates 
and dissolves rapidly with enhanced dissolution. An 
extension of market exclusivity, which can be provided by 
immediate release dosage form, leads to increased revenue, 
while also targeting underserved and under-treated patient 
populations.
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